COPD Pathogenesis
Inflammation is present in the lungs, especially the small airway routes, of all people who smoke. COPD Pathogenesis is typical defensive reaction to the inhaled toxins is enhanced in COPD, leading to tissue destruction, debilitation of the defence mechanisms and interruption of the repair mechanisms. In general, the inflammatory and structural changes in the airway routes increased with disease seriousness and hold on even after smoking cessation. Other than inflammation, two different procedures are associated with the pathogenesis of COPD—an irregularity amongst proteases and ant proteases and an imbalance amongst oxidants and antioxidants agents in the lungs. Pulmonary Conferences expresses various developing treatments for COPD.
- Airway inflammation
- Mucociliary dysfunction
- Mucociliary dysfunction Protease imbalance
- Antiprotease imbalance
Related Conference of COPD Pathogenesis
16th International Conference on Pulmonary & Respiratory Medicine
18th International Conference on Chronic Obstructive Pulmonary Disease
COPD Pathogenesis Conference Speakers
Recommended Sessions
- Asthma and Allergy
- Chronic Obstructive Pulmonary Disease
- COPD Pathogenesis
- Emphysema
- Idiopathic pulmonary fibrosis
- Influenza
- Interstistial Lung Disease
- Lung Homeostasis
- Lung transplantation
- Paediatric Pulmonology & Critical care
- Pediatric and Geriatric Gastroenterology
- Pneumonia
- Pulmonary diseases: Treatment, Diagnosis and therapy
- Pulmonary hypertension
- Pulmonary Physiology
- Pulmonary rehabilitation
- Respiratory framework
Related Journals
Are you interested in
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- COPD Innovations - PULMONOLOGY 2026 (France)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
